Global Digestive Aids Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Digestive Aids Market Research Report 2024
Digestive aids are products, substances, or techniques used to support and improve the process of digestion within the human body.
According to Mr Accuracy reports’s new survey, global Digestive Aids market is projected to reach US$ 4004.7 million in 2029, increasing from US$ 1845 million in 2022, with the CAGR of 12.6% during the period of 2024 to 2029.
Digestive aids are medications used to improve the functioning of the gastrointestinal tract, facilitate the digestion of food and relieve symptoms of indigestion. These medications are widely used in clinical practice, especially in the treatment of gastrointestinal problems, stomach ulcers, heartburn, gastroesophageal reflux disease (GERD) and other digestive disorders. Antacid medications such as proton pump inhibitors (PPIs) and H2 receptor antagonists (H2RAs) remain the mainstay of treatment for GERD and gastric ulcers. Although they are very effective, long-term use can lead to a number of side effects and safety concerns, so researchers are seeking safer alternatives. Probiotics and prebiotics are believed to be beneficial for gut health, improving the balance of intestinal flora and positively affecting digestion and the immune system. These products have become part of the market for digestive aids and new research continues to support their effectiveness. A number of natural herbs and herbal remedies are widely used to treat indigestion and gastrointestinal problems. These include turmeric, peppermint, wormwood and aloe vera. Researchers are delving into the efficacy and safety of these botanical medicines. Overall, the field of digestive aid medications is evolving, with researchers and doctors striving to find safer and more effective treatments, as well as a growing emphasis on the importance of personalised treatment and a healthy diet. In the future, as medical science continues to advance, we can expect to see more innovative and improved digestive aids and treatments.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Digestive Aids market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Roche Holding
Abbvie
Bayer
Pfizer
Biogen
Johnson & Johnson
Takeda Pharmaceutical
Amgen
Sanofi
Novozymes
Metagenics
Enzymedica
o., Ltd.
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Yabao Pharmaceutical Group Co., Ltd.
ZhuZhou QianJin Pharmaceutical Co., Ltd.
Zhejiang Yatai Pharmaceutical Co., Ltd.
Zhejiang East-Asia Pharmaceutical Co., Ltd.
Guangdong Sunho Pharmaceutical Co., Ltd.
Cisen Pharmaceutical Co., Ltd.
Hunan Jingfeng Pharmaceutical Co., Ltd.
Tibet Aim Pharm. Inc.
Medifactia
Konsyl Pharmaceuticals,Inc
Segment by Type
Gastrointestinal Dynamics
Digestive Enzyme Drugs
Antacids
Antigastrics
Hospitals
Clinics
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Digestive Aids report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Digestive Aids market is projected to reach US$ 4004.7 million in 2029, increasing from US$ 1845 million in 2022, with the CAGR of 12.6% during the period of 2024 to 2029.
Digestive aids are medications used to improve the functioning of the gastrointestinal tract, facilitate the digestion of food and relieve symptoms of indigestion. These medications are widely used in clinical practice, especially in the treatment of gastrointestinal problems, stomach ulcers, heartburn, gastroesophageal reflux disease (GERD) and other digestive disorders. Antacid medications such as proton pump inhibitors (PPIs) and H2 receptor antagonists (H2RAs) remain the mainstay of treatment for GERD and gastric ulcers. Although they are very effective, long-term use can lead to a number of side effects and safety concerns, so researchers are seeking safer alternatives. Probiotics and prebiotics are believed to be beneficial for gut health, improving the balance of intestinal flora and positively affecting digestion and the immune system. These products have become part of the market for digestive aids and new research continues to support their effectiveness. A number of natural herbs and herbal remedies are widely used to treat indigestion and gastrointestinal problems. These include turmeric, peppermint, wormwood and aloe vera. Researchers are delving into the efficacy and safety of these botanical medicines. Overall, the field of digestive aid medications is evolving, with researchers and doctors striving to find safer and more effective treatments, as well as a growing emphasis on the importance of personalised treatment and a healthy diet. In the future, as medical science continues to advance, we can expect to see more innovative and improved digestive aids and treatments.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Digestive Aids market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche Holding
Abbvie
Bayer
Pfizer
Biogen
Johnson & Johnson
Takeda Pharmaceutical
Amgen
Sanofi
Novozymes
Metagenics
Enzymedica
o., Ltd.
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Yabao Pharmaceutical Group Co., Ltd.
ZhuZhou QianJin Pharmaceutical Co., Ltd.
Zhejiang Yatai Pharmaceutical Co., Ltd.
Zhejiang East-Asia Pharmaceutical Co., Ltd.
Guangdong Sunho Pharmaceutical Co., Ltd.
Cisen Pharmaceutical Co., Ltd.
Hunan Jingfeng Pharmaceutical Co., Ltd.
Tibet Aim Pharm. Inc.
Medifactia
Konsyl Pharmaceuticals,Inc
Segment by Type
Gastrointestinal Dynamics
Digestive Enzyme Drugs
Antacids
Antigastrics
Segment by Application
Hospitals
Clinics
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Digestive Aids report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices